These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32453600)

  • 1. Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.
    Maron BA
    Am J Respir Crit Care Med; 2020 Aug; 202(4):488-490. PubMed ID: 32453600
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of genetics in pulmonary arterial hypertension associated with congenital heart disease.
    Cruz-Utrilla A; Gallego N; Segura de la Cal T; Tenorio-Castaño J; Arribas-Ynsaurriaga F; Escribano Subias P
    Rev Esp Cardiol (Engl Ed); 2021 Oct; 74(10):884-886. PubMed ID: 33972189
    [No Abstract]   [Full Text] [Related]  

  • 3. PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
    Aldred MA
    Am J Respir Crit Care Med; 2020 Dec; 202(11):1500-1502. PubMed ID: 32835509
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension.
    Ayon RJ; Yuan JX
    Am J Respir Cell Mol Biol; 2023 Aug; 69(2):123-125. PubMed ID: 37201951
    [No Abstract]   [Full Text] [Related]  

  • 5. Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
    Simpson CE; Hassoun PM
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1377-1379. PubMed ID: 35452380
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulating the Regulators: Epigenetic Modulation of Regulatory T Cells in Pulmonary Hypertension.
    Farha S; Aldred MA
    Am J Respir Crit Care Med; 2023 Oct; 208(8):834-836. PubMed ID: 37682657
    [No Abstract]   [Full Text] [Related]  

  • 7. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
    Aman J; Hovingh GK
    Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
    [No Abstract]   [Full Text] [Related]  

  • 8. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Austin ED; Hamid R
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
    [No Abstract]   [Full Text] [Related]  

  • 9. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
    [No Abstract]   [Full Text] [Related]  

  • 10. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
    Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Grinnan D; Farkas L
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-World Data for Pulmonary Arterial Hypertension.
    Elliott CG
    Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
    [No Abstract]   [Full Text] [Related]  

  • 13. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Maron BA; Humbert M
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].
    Fan FL; Zhang SL; Song Q; Xie XG; Zhang YP; Huo XW; Zou YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):621-625. PubMed ID: 32842275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
    Durrani J; Toor A
    Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369
    [No Abstract]   [Full Text] [Related]  

  • 16. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Pullamsetti SS; de Jesus Perez VA
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
    [No Abstract]   [Full Text] [Related]  

  • 17. The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Ormiston ML; Godoy RS; Chaudhary KR; Stewart DJ
    Circ Res; 2019 Mar; 124(6):822-824. PubMed ID: 30870124
    [No Abstract]   [Full Text] [Related]  

  • 18. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Calcaterra G; Fanos V; Bassareo PP
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923176
    [No Abstract]   [Full Text] [Related]  

  • 19. Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
    Merkus D; van Beusekom HMM; Boomars KA
    Cardiovasc Res; 2019 Jul; 115(8):1260-1261. PubMed ID: 30903137
    [No Abstract]   [Full Text] [Related]  

  • 20. Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Rosenzweig EB; Abman SH; Berger RMF
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.